Tartrate-Resistant Acid Phosphatase Deficiency in the Predisposition to Systemic Lupus Erythematosus

Arthritis and Rheumatology

Volumn 69, Issue 1, 2017, Pages 131-142

  An, Jie ^a   Briggs, Tracy A ^b   Dumax Vorzet, Audrey ^c   Alarcón Riquelme, Marta E ^d   Belot, Alexandre ^e   Beresford, Michael ^f   Bruce, Ian N ^g   Carvalho, Claudia ^h   Chaperot, Laurence ⁱ   Frostegård, Johan ^j   Plumas, Joel ⁱ   Rice, Gillian I ^c   Vyse, Timothy J ^k   Wiedeman, Alice ^a   Crow, Yanick J ^c   Elkon, Keith B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF GRANADA   (Spain)

^e CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^h UNIVERSITY OF PORTO   (Portugal)

ⁱ INSTITUTE FOR ADVANCED BIOSCIENCES   (France)

^j KAROLINSKA INSTITUTE   (Sweden)

^k GUY S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALPHA INTERFERON; INTERFERON REGULATORY FACTOR 7; OSTEOPONTIN; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 9; ACP5 PROTEIN, HUMAN;

ACP5 GENE; ARTICLE; CONFOCAL MICROSCOPY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENZYME DEFICIENCY; GENE; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOPRECIPITATION; MACROPHAGE; MASS SPECTROMETRY; MISSENSE MUTATION; NEXT GENERATION SEQUENCING; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SANGER SEQUENCING; SYSTEMIC LUPUS ERYTHEMATOSUS; TARTRATE RESISTANT ACID PHOSPHATASE DEFICIENCY; WESTERN BLOTTING; AUTOIMMUNE DISEASE; CHONDRODYSPLASIA; DEFICIENCY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MUTATION; PHOSPHORYLATION;

AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MUTATION; OSTEOCHONDRODYSPLASIAS; OSTEOPONTIN; PHOSPHORYLATION; TARTRATE-RESISTANT ACID PHOSPHATASE;

EID: 85006172833     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39810     Document Type: Article

References (32)

1. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285–90.
2. Hayman AR, Macary P, Lehner PJ, Cox TM. Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells. J Histochem Cytochem 2001;49:675–84.
3. Hayman AR, Bune AJ, Bradley JR, Rashbass J, Cox TM. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localization to dendritic cells and diverse murine tissues. J Histochem Cytochem 2000;48:219–28.
4. Chu P, Chao TY, Lin YF, Janckila AJ, Yam LT. Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis 2003;41:1052–9.
5. Henriksen K, Tanko LB, Qvist P, Delmas PD, Christiansen C, Karsdal MA. Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases. Osteoporos Int 2007;18:681–5.
6. Rissanen JP, Suominen MI, Peng Z, Halleen JM. Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int 2008;82:108–15.
7. Janckila AJ, Yam LT. Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme. Calcif Tissue Int 2009;85:465–83.
8. Hayman AR. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 2008;41:218–23.
9. Ek-Rylander B, Flores M, Wendel M, Heinegård D, Andersson G. Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase: modulation of osteoclast adhesion in vitro. J Biol Chem 1994;269:14853–6.
10. Inoue M, Shinohara ML. Intracellular osteopontin (iOPN) and immunity. Immunol Res 2011;49:160–72.
11. Briggs TA, Rice GI, Daly S, Urquhart J, Gornall H, Bader-Meunier B, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 2011;43:127–31.
12. Lausch E, Janecke A, Bros M, Trojandt S, Alanay Y, de Laet C, et al. Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet 2011;43:132–7.
13. Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, et al. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 1996;122:3151–62.
14. Patarca R, Saavedra RA, Cantor H. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 1993;13:225–46.
15. Trivedi T, Franek BS, Green SL, Kariuki SN, Kumabe M, Mikolaitis RA, et al. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol 2011;2011:802581.
16. Shinohara ML, Lu L, Bu J, Werneck MB, Kobayashi KS, Glimcher LH, et al. Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells. Nat Immunol 2006;7:498–506.
17. Lang P, Andersson G. Differential expression of monomeric and proteolytically processed forms of tartrate-resistant acid phosphatase in rat tissues. Cell Mol Life Sci 2005;62:905–18.
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
19. Strater N, Jasper B, Scholte M, Krebs B, Duff AP, Langley DB, et al. Crystal structures of recombinant human purple acid phosphatase with and without an inhibitory conformation of the repression loop. J Mol Biol 2005;351:233–46.
20. Ljusberg J, Ek-Rylander B, Andersson G. Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases. Biochem J 1999;343:63–9.
21. Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sjolander J, Lang P, Norgard M, et al. TRACP as an osteopontin phosphatase. J Bone Miner Res 2003;18:1912–5.
22. Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001;97:3210–7.
23. Liu Y, Shi Z, Silveira A, Liu J, Sawadogo M, Yang H, et al. Involvement of upstream stimulatory factors 1 and 2 in RANKL-induced transcription of tartrate-resistant acid phosphatase gene during osteoclast differentiation. J Biol Chem 2003;278:20603–11.
24. Christensen B, Klaning E, Nielsen MS, Andersen MH, Sorensen ES. C-terminal modification of osteopontin inhibits interaction with the αVβ3-integrin. J Biol Chem 2012;287:3788–97.
25. Wang KX, Denhardt DT. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev 2008;19:333–45.
26. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008;8:594–606.
27. Briggs TA, Rice GI, Adib N, Ades L, Barete S, Baskar K, et al. Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey. J Clin Immunol 2016;36:220–34.
28. Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, et al. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet 2012;44:1243–8.
29. Flores ME, Norgard M, Heinegård D, Reinholt FP, Andersson G. RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin. Exp Cell Res 1992;201:526–30.
30. Bune AJ, Hayman AR, Evans MJ, Cox TM. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus. Immunology 2001;102:103–13.
31. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol 2002;72:752–61.
32. Ek-Rylander B, Andersson G. Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Exp Cell Res 2010;316:443–51.